Literature DB >> 14518142

Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children.

David Gaón1, Hugo García, Luis Winter, Nora Rodríguez, Ricardo Quintás, Silvia N González, Guillermo Oliver.   

Abstract

The efficacy of probiotics on persistent diarrhea remains uncertain. The purpose of this study was to evaluate the effect of Lactobacillus sp and Saccharomyces boulardii on persistent diarrhea in children. In a double-blind trial eighty-nine children, aged 6-24 months were randomly distributed to receive pasteurized cow milk containing 2 viable lyophilized strains Lactobacillus casei and Lactobacillus acidophillus strains CERELA, (10(10)-10(12) colony-forming units per g) (n = 30), or lyophilized S. boulardii, (10(10)-10(12) colony forming units per g) (n = 30) or pasteurized cow milk as placebo (n = 29); on each diet 175 g was given twice a day for a 5 day period. Number of depositions, duration of illness and frequency of vomiting were considered. Enteric pathogens were isolated from stools in 40% of the patients, 27% had rotavirus. Lactobacillus and S. boulardii significantly reduced the number of depositions (p < 0.001) and diarrheal duration (p < 0.005). Similarly both significantly (p < 0.002) reduced vomiting as compared with placebo. There was no difference between treatments depending on rotavirus status. In conclusion, L. casei and L. acidophillus strains CERELA and S. boulardii are useful in the management of persistent diarrhea in children.

Entities:  

Mesh:

Year:  2003        PMID: 14518142

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  22 in total

Review 1.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

2.  Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.

Authors:  V Sreeja; Jashbhai B Prajapati
Journal:  Probiotics Antimicrob Proteins       Date:  2013-06       Impact factor: 4.609

Review 3.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

Review 4.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

5.  Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.

Authors:  Makbule Eren; Ener C Dinleyici; Yvan Vandenplas
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

6.  Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status.

Authors:  Néstor Pérez; Juan C Iannicelli; Cecilia Girard-Bosch; Silvia González; Ana Varea; Liliana Disalvo; María Apezteguia; Juan Pernas; Dimas Vicentin; Ricardo Cravero
Journal:  Eur J Nutr       Date:  2009-10-17       Impact factor: 5.614

7.  Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

Authors:  Miriam Schlee; Jan Wehkamp; Artur Altenhoefer; Tobias A Oelschlaeger; Eduard F Stange; Klaus Fellermann
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 8.  Saccharomyces boulardii in childhood.

Authors:  Yvan Vandenplas; Oscar Brunser; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

Review 9.  Probiotics for treating persistent diarrhoea in children.

Authors:  Guillermo Bernaola Aponte; Carlos Alfonso Bada Mancilla; Nilton Yhuri Carreazo; Raúl Alberto Rojas Galarza
Journal:  Cochrane Database Syst Rev       Date:  2013-08-20

Review 10.  Emerging roles of lactic acid bacteria in protection against colorectal cancer.

Authors:  Li Zhong; Xufei Zhang; Mihai Covasa
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.